149 related articles for article (PubMed ID: 3791224)
1. Pharmacokinetics of N-nitrosodimethylamine in beagles.
Gombar CT; Pylypiw HM; Harrington GW
Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224
[TBL] [Abstract][Full Text] [Related]
2. Low-dose in vivo pharmacokinetic and deuterium isotope effect studies of N-nitrosodimethylamine in rats.
Mico BA; Swagzdis JE; Hu HS; Keefer LK; Oldfield NF; Garland WA
Cancer Res; 1985 Dec; 45(12 Pt 1):6280-5. PubMed ID: 4063978
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of N-nitrosodimethylamine in swine.
Gombar CT; Harrington GW; Pylypiw HM; Bevill RF; Thurmon JC; Nelson DR; Magee PN
Carcinogenesis; 1988 Aug; 9(8):1351-4. PubMed ID: 3402031
[TBL] [Abstract][Full Text] [Related]
4. Interspecies scaling of the pharmacokinetics of N-nitrosodimethylamine.
Gombar CT; Harrington GW; Pylypiw HM; Anderson LM; Palmer AE; Rice JM; Magee PN; Burak ES
Cancer Res; 1990 Jul; 50(14):4366-70. PubMed ID: 2364390
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
[TBL] [Abstract][Full Text] [Related]
7. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
8. Metabolic denitrosation of N-nitrosodimethylamine in vivo in the rat.
Streeter AJ; Nims RW; Sheffels PR; Heur YH; Yang CS; Mico BA; Gombar CT; Keefer LK
Cancer Res; 1990 Feb; 50(4):1144-50. PubMed ID: 2297762
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
[TBL] [Abstract][Full Text] [Related]
10. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
Woodworth JR; Owens SM; Mayersohn M
J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
Christ DD; Wong PC; Wong YN; Hart SD; Quon CY; Lam GN
J Pharmacol Exp Ther; 1994 Mar; 268(3):1199-205. PubMed ID: 8138932
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of dihydroergotamine in the beagle.
Mäntylä R; Kleimola T; Kanto J
Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):124-8. PubMed ID: 649230
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
14. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
16. Toxicokinetics of N-nitrosodimethylamine in the Syrian golden hamster.
Streeter AJ; Nims RW; Wu PP; Logsdon DL
Arch Toxicol; 1990; 64(7):562-6. PubMed ID: 2073129
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of N-nitrosodimethylamine metabolism in rats by ether anesthesia.
Keefer LK; Garland WA; Oldfield NF; Swagzdis JE; Mico BA
Cancer Res; 1985 Nov; 45(11 Pt 1):5457-60. PubMed ID: 4053020
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of coumarin and 7-hydroxycoumarin upon i.v. and p.o. administration in the euthyroid and hypothyroid beagle dog.
Ritschel WA; Grummich KW
Arzneimittelforschung; 1981; 31(4):643-9. PubMed ID: 7195711
[TBL] [Abstract][Full Text] [Related]
19. Suppression of in vivo clearance of N-nitrosodimethylamine in mice by cotreatment with ethanol.
Anderson LM; Koseniauskas R; Burak ES; Logsdon DL; Carter JP; Driver CL; Gombar CT; Magee PN; Harrington GW
Drug Metab Dispos; 1994; 22(1):43-9. PubMed ID: 8149888
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
Chism JP; Rickert DE
Drug Metab Dispos; 1996 Jan; 24(1):34-40. PubMed ID: 8825188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
